| |
| |
| Exchange: |
Over The Counter |
| Security
Type: |
Common |
| Shares
Out: |
570,750,000 |
| Market
Cap: |
76.54(M) |
| Last
Volume: |
3,709,408 |
Avg
Vol: |
3,188,549 |
| 52
Week Range: |
$0.1356 - $0.3 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile CytoDyn is a clinical-stage biotechnology company focused on the clinical development of treatments for multiple therapeutic indications based on its product candidate, leronlimab, a humanized monoclonal antibody targeting the C-C chemokine receptor type 5 receptor. Leronlimab is being investigated as a viral entry inhibitor for Human Immunodeficiency Virus. Leronlimab is also being studied in oncology, as well as other therapeutic indications, including coronavirus disease.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-03-17 |
2023-12-15 |
2023-06-16 |
2022-06-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Caracciolo Anthony |
Director |
– • – |
2018-11-16 |
4 |
A |
$0.00 |
$0 |
D/D |
62,136 |
62,136 |
|
- |
|
| Caracciolo Anthony |
Director |
– • – |
2018-11-16 |
4 |
A |
$0.00 |
$0 |
I/I |
2,319,972 |
26,000 |
|
- |
|
| Naydenov Jordan G |
Director |
– • – |
2018-11-16 |
4 |
A |
$0.00 |
$0 |
D/D |
5,304,490 |
5,304,490 |
|
- |
|
| Kelly Scott A. |
Director |
– • – |
2018-11-16 |
4 |
A |
$0.00 |
$0 |
I/I |
737,368 |
22,980 |
|
- |
|
| Kelly Scott A. |
Director |
– • – |
2018-11-16 |
4 |
A |
$0.00 |
$0 |
D/D |
1,243,170 |
1,243,170 |
|
- |
|
| Pourhassan Nader |
President and CEO |
• • – |
2018-11-16 |
4 |
A |
$0.00 |
$0 |
I/I |
15,750 |
15,750 |
|
- |
|
| Pourhassan Nader |
President and CEO |
• • – |
2018-11-16 |
4 |
A |
$0.00 |
$0 |
D/D |
161,489 |
161,489 |
|
- |
|
| Klump Michael A |
Director |
– • – |
2018-11-16 |
4 |
A |
$0.00 |
$0 |
I/I |
7,034,520 |
7,034,520 |
|
- |
|
| Naydenov Jordan G |
Director |
– • – |
2018-11-16 |
4 |
D |
$0.00 |
$0 |
D/D |
(5,304,490) |
0 |
|
- |
|
| Pourhassan Nader |
President and CEO |
• • – |
2018-11-16 |
4 |
D |
$0.00 |
$0 |
I/I |
(15,750) |
0 |
|
- |
|
| Pourhassan Nader |
President and CEO |
• • – |
2018-11-16 |
4 |
D |
$0.00 |
$0 |
D/D |
(161,489) |
0 |
|
- |
|
| Caracciolo Anthony |
Director |
– • – |
2018-11-16 |
4 |
D |
$0.00 |
$0 |
D/D |
(62,136) |
0 |
|
- |
|
| Caracciolo Anthony |
Director |
– • – |
2018-11-16 |
4 |
D |
$0.00 |
$0 |
I/I |
(2,319,972) |
0 |
|
- |
|
| Dockery Carl |
Director |
– • – |
2018-11-16 |
4 |
D |
$0.00 |
$0 |
I/I |
(7,578,095) |
0 |
|
- |
|
| Kelly Scott A. |
Director |
– • – |
2018-11-16 |
4 |
D |
$0.00 |
$0 |
I/I |
(737,368) |
0 |
|
- |
|
| Kelly Scott A. |
Director |
– • – |
2018-11-16 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,243,170) |
0 |
|
- |
|
| Mulholland Michael D |
CFO, Treasurer and Secretary |
• – – |
2018-11-16 |
4 |
D |
$0.00 |
$0 |
D/D |
(87,126) |
0 |
|
- |
|
| Klump Michael A |
Director |
– • – |
2018-11-16 |
4 |
D |
$0.00 |
$0 |
I/I |
(7,034,520) |
0 |
|
- |
|
| Gould Gregory A |
Director |
– • – |
2018-11-16 |
4 |
D |
$0.00 |
$0 |
D/D |
(19,176) |
0 |
|
- |
|
| Mulholland Michael D |
CFO, Treasurer and Secretary |
• – – |
2018-03-15 |
4 |
D |
$0.69 |
$26,726 |
D/D |
(38,733) |
87,126 |
|
- |
|
| Mulholland Michael D |
CFO, Treasurer and Secretary |
• – – |
2018-03-15 |
4 |
A |
$0.00 |
$0 |
D/D |
88,816 |
125,859 |
|
- |
|
| Pourhassan Nader |
President and CEO |
• • – |
2018-03-15 |
4 |
D |
$0.69 |
$82,992 |
D/D |
(120,278) |
161,489 |
|
- |
|
| Pourhassan Nader |
President and CEO |
• • – |
2018-03-15 |
4 |
A |
$0.00 |
$0 |
D/D |
221,711 |
281,767 |
|
- |
|
| Dockery Carl |
Director |
– • – |
2018-01-31 |
4 |
A |
$0.00 |
$0 |
I/I |
103,586 |
7,578,095 |
|
- |
|
| Naydenov Jordan G |
Director |
– • – |
2018-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
207,248 |
5,304,490 |
|
- |
|
381 Records found
|
|
Page 6 of 16 |
|
|
